# Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector

> **NCT01765426** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 67 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** TDV
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01765426
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-15
- **Primary completion:** 2014-06-26
- **Final completion:** 2014-06-26
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2019-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765426, "Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01765426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*